Atlas Trials

Pulmonary Neoplasms

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pulmonary Neoplasms

RecordFirmDate
Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® (NCT05011890)UNC Lineberger Comprehensive Cancer Center2021-09-01
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation (NCT04699188)Novartis Pharmaceuticals2021-02-24
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer (NCT02410603)Mayo Clinic2016-12-01
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) (NCT02673021)Mayo Clinic2016-06-08
RejuvenAir Lobectomy for Safety and Histology (NCT02483052)CSA Medical, Inc.2015-08-01
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma (NCT02549638)Mayo Clinic2015-04-08
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System (NCT02370303)Mayo Clinic2014-08-01
Study of Arsenic Trioxide in Small Cell Lung Cancer (NCT01470248)Emory University2011-08-01
A Phase I Study of iPS Cell Generation From Patients With COPD (NCT01860898)Mayo Clinic2009-09-01
Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath (NCT00922155)Chang Gung Memorial Hospital2007-04-01
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease (NCT00241267)University Hospital, Tours2005-03-01
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms (NCT00232128)Oncology Specialties, Alabama2003-06-01
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) (NCT00132639)Haruhiko Fukuda2002-10-01
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide (NCT00290953)Sanofi2002-10-01
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. (NCT00042679)Eli Lilly and Company2002-06-01

Track Pulmonary Neoplasms automatically

Every clearance here is in the API, with alerts when new ones post.